The psychosis risk syndrome and its proposed inclusion in the DSM-V: A risk–benefit analysis
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The inclusion of a psychosis risk syndrome has been proposed for the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders. The appropriateness of inclusion of this new risk syndrome in the DSM depends on a careful analysis of both anticipated benefits and risks. Purported benefits include early recognition and case identification, and the hypothetical benefit of preventive intervention of psychotic disorders, for which there is as yet no evidence base. However, there is a potential for high rates of false positives – both at the expert and community level – given the difficulty in discriminating mild symptoms from normal variants and low base rates of the syndrome in the general population. High false positive rates in and of themselves are not necessarily problematic if the risk-benefit ratio is significantly favorable, as with screening for cardiovascular risk factors. For the psychosis risk syndrome, by contrast, there are substantial risks, for both stigma and discrimination, and for unnecessary exposure to antipsychotic medications, which arguably make the high false positive rate associated with the psychosis risk designation untenable. Improvement of the positive predictive value of the psychosis risk syndrome is necessary to enhance its candidacy for inclusion in future editions of the DSM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 2×
“…the Framingham Heart Study showed that most individuals with mild hypertension or elevated total cholesterol do not develop coronary heart disease (Wilson et al., 1998), screening for these risk factors is widely accepted and promoted given that the potential benefits of early intervention are…”
BackgroundLink, B. G., & Phelan, J. C. (2001) · Annual Review of Sociology · doi:10.1146/annurev.soc.27.1.363 · Cited by 8,848
A Modified Labeling Theory Approach to Mental Disorders: An Empirical Assessment
Link, B. G., Cullen, F. T., Struening, E., Shrout, P. E., & Dohrenwend, B. P. (1989) · American Sociological Review · doi:10.2307/2095613 · Cited by 1,935 · cited 1×
“For serious mental illness, the label of mental disorder is typically associated with undesirable characteristics, such that individuals with this label are stereotyped in a negative way (Link et al., 1989).”
BackgroundChild developmental risk factors for adult schizophrenia in the British 1946 birth cohort
JONES, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90569-x · Cited by 1,353 · cited 1×
“For example, individuals who go on to develop schizophrenia have a history of developmental delays, isolated play and speech problems, and some clumsiness, as compared with normal controls (Done et al., 1994; Fish et al., 1992; Jones et al., 1994; Tarrant and Jones, 1999).”
BackgroundCannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Seidman, L. J., Perkins, D., Tsuang, M., McGlashan, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.3 · Cited by 1,269
Self-citationPsychosis prediction: 12-month follow up of a high-risk ("prodromal") group
Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S. M., McFarlane, C. A., Hallgren, M., & McGorry, P. D. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00167-6 · Cited by 1,136
McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.921 · Cited by 1,056 · cited 4×
“As yet there is no clear evidence base, and there have been only a handful of clinical trials which are promising but not conclusive, comprising not only antipsychotics (McGorry et al., 2002), which are sometimes associated with significant side effects (McGlashan et al.”
BackgroundInfluentialAmminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., & Berger, G. E. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.192 · Cited by 896
Morrison, A. P., French, P., Walford, L., Lewis, S. W., Kilcommons, A., Green, J., Parker, S., & Bentall, R. P. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.4.291 · Cited by 740
Psychotic symptoms in non-clinical populations and the continuum of psychosis
Verdoux, H., & van Os, J. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00352-8 · Cited by 557
Cited by
The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review
Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.269 · Cited by 1,483
Self-citationPredicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk
Fusar-Poli, P. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1472 · Cited by 1,361
Psychosis risk screening with the Prodromal Questionnaire — Brief Version (PQ-B)
Loewy, R. L., Pearson, R., Vinogradov, S., Bearden, C. E., & Cannon, T. D. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.029 · Cited by 496
Long-term Follow-up of a Group at Ultra High Risk (“Prodromal”) for Psychosis: The PACE 400 Study
Nelson, B., Yuen, H. P., Wood, S. J., Lin, A., Spiliotacopoulos, D., Bruxner, A., Broussard, C., Simmons, M., Foley, D. L., Brewer, W. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1270 · Cited by 433
Gerlinger, G., Hauser, M., De Hert, M., Lacluyse, K., Wampers, M., & Correll, C. U. (2013) · World Psychiatry · doi:10.1002/wps.20040 · Cited by 383
Zammit, S., Kounali, D., Cannon, M., David, A. S., Gunnell, D., Heron, J., Jones, P. B., Lewis, S., Sullivan, S., Wolke, D., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12060768 · Cited by 319
The Continuum of Psychotic Symptoms in the General Population: A Cross-national Study
Nuevo, R., Chatterji, S., Verdes, E., Naidoo, N., Arango, C., & Ayuso-Mateos, J. L. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq099 · Cited by 340
Cognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysis
Hutton, P., & Taylor, P. J. (2014) · Psychological Medicine · doi:10.1017/s0033291713000354 · Cited by 184
“This has sparked much controversy and debate (Corcoran et al. 2010; Yung et al. 2010), and it seems such proposals have now been set aside.”
BackgroundGronholm, P. C., Thornicroft, G., Laurens, K. R., & Evans-Lacko, S. (2017) · Psychological Medicine · doi:10.1017/s0033291717000344 · Cited by 181
Preti, A., & Cella, M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.026 · Cited by 167
Yang, L. H., Wonpat-Borja, A. J., Opler, M. G., & Corcoran, C. M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.03.012 · Cited by 157
Self-citationRössler, W., Hengartner, M. P., Ajdacic-Gross, V., Haker, H., Gamma, A., & Angst, J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.019 · Cited by 103
“, 2003, 2004), and it has been argued that there is a potential for high rates of false-positive cases, with a substantial risk of stigma and discrimination (Corcoran et al., 2010).”
‘At risk mental state’ clinics for psychosis – an idea whose time has come – and gone!
Ajnakina, O., David, A. S., & Murray, R. M. (2019) · Psychological Medicine · doi:10.1017/s0033291718003859 · Cited by 82
“However, it has been reported that as many as 84% of those individuals who were identified as being at risk for the illness using these scales did not develop a psychotic disorder within 2 – 3 years (i.e. these individuals are normally referred to as ‘ false positives ’ ) (Corcoran et al ., 2010).”
Pyle, M., Stewart, S. L. K., French, P., Byrne, R., Patterson, P., Gumley, A., Birchwood, M., & Morrison, A. P. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12098 · Cited by 57
Attitudes towards help-seeking and stigma among young people at risk for psychosis
Rüsch, N., Heekeren, K., Theodoridou, A., Dvorsky, D., Müller, M., Paust, T., Corrigan, P. W., Walitza, S., & Rössler, W. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.08.028 · Cited by 53
Early prodromal symptoms can predict future psychosis in familial high-risk youth
Tandon, N., Montrose, D., Shah, J., Rajarethinam, R. P., Diwadkar, V. A., & Keshavan, M. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.019 · Cited by 52
“Although the proposal is controversial (Corcoran et al., 2010; Drake and Lewis, 2010; Woods et al., 2010), its utility rests in part on the availability of reliable and valid”
Anglin, D. M., Greenspoon, M. I., Lighty, Q., Corcoran, C. M., & Yang, L. H. (2014) · Early Intervention in Psychiatry · doi:10.1111/eip.12047 · Cited by 35
Self-citationAre current labeling terms suitable for people who are at risk of psychosis?
Kim, S.-W., Polari, A., Melville, F., Moller, B., Kim, J.-M., Amminger, P., Herrman, H., McGorry, P., & Nelson, B. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.027 · Cited by 25
“One of the key reasons for not including the ‘APS’ was the concern about stigmatising young patients with a “psychosis risk” label (Corcoran, 2016; Corcoran et al., 2010; Lee et al., in press; Mittal et al., 2015).”
Metadata
- Authors
- Corcoran, C. M., First, M. B., & Cornblatt, B.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 120
- Issue
- 1-3
- Pages
- 16-22
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2011194880
- Cited by
- 128
- References
- 16
- FWCI
- 14.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.